106 related articles for article (PubMed ID: 18608528)
1. Immunomodulatory activity of synthetic triterpenoids: inhibition of lymphocyte proliferation, cell-mediated cytotoxicity, and cytokine gene expression through suppression of NF-kappaB.
Gao X; Deeb D; Danyluk A; Media J; Liu Y; Dulchavsky SA; Gautam SC
Immunopharmacol Immunotoxicol; 2008; 30(3):581-600. PubMed ID: 18608528
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.
Gao X; Deeb D; Liu Y; Gautam S; Dulchavsky SA; Gautam SC
Immunopharmacol Immunotoxicol; 2009; 31(3):477-84. PubMed ID: 19555200
[TBL] [Abstract][Full Text] [Related]
3. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
4. A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.
Shishodia S; Sethi G; Konopleva M; Andreeff M; Aggarwal BB
Clin Cancer Res; 2006 Mar; 12(6):1828-38. PubMed ID: 16551868
[TBL] [Abstract][Full Text] [Related]
5. CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2008; 7(1):31-9. PubMed ID: 18472640
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production.
Gao X; Xu YX; Janakiraman N; Chapman RA; Gautam SC
Biochem Pharmacol; 2001 Nov; 62(9):1299-308. PubMed ID: 11705464
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation.
Wong VK; Zhou H; Cheung SS; Li T; Liu L
J Cell Biochem; 2009 May; 107(2):303-15. PubMed ID: 19301261
[TBL] [Abstract][Full Text] [Related]
9. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive properties of electrophoretically "slow" and "fast" form alpha 2-macroglobulin. Effects on cell-mediated cytotoxicity and (allo-) antigen-induced T cell proliferation.
Petersen CM; Ejlersen E; Moestrup SK; Jensen PH; Sand O; Sottrup-Jensen L
J Immunol; 1989 Jan; 142(2):629-35. PubMed ID: 2463311
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
[TBL] [Abstract][Full Text] [Related]
15. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A
J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice.
Gao C; Jiang J; Ma P; Cheng P; Lian Y; Zhao B; Li C; Peng Y; Wang F; Lin Y; Jin N; Li J; Wang L; Li Q; Leng Y; Xia J; Qi Z
Transplantation; 2015 Sep; 99(9):1796-806. PubMed ID: 25919768
[TBL] [Abstract][Full Text] [Related]
17. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
18. CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.
Deeb D; Gao X; Dulchavsky SA; Gautam SC
Anticancer Res; 2007; 27(5A):3035-44. PubMed ID: 17970042
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of cytotoxic T lymphocytes and lymphokine-activated killer cells to inhibition by L-ornithine.
Susskind BM; Sekar J; Tandon PM; Lind DS; Bear HD
Cell Immunol; 1991 Mar; 133(1):41-54. PubMed ID: 1899361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
